Prevalence and Outcomes of Breathlessness in Older Adults: A National Population Study

Journal of the American Geriatrics Society

Volumn 64, Issue 10, 2016, Pages 2035-2041

  Smith, Alexander K ^a,b   Currow, David C ^c   Abernethy, Amy P ^a,d   Johnson, Miriam J ^e   Miao, Yinghui ^a,c   Boscardin, W John ^a,b   Ritchie, Christine S ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c FLINDERS UNIVERSITY   (Australia)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF HULL   (United Kingdom)

^f Jewish Home of San Francisco   (United States)

Author keywords

breathlessness; decline; older

Indexed keywords

ADL DISABILITY; AGED; ANXIETY; ARTICLE; CHRONIC LUNG DISEASE; COMORBIDITY; CONFIDENCE INTERVAL; DEATH; DEPRESSION; DISEASE SEVERITY; DYSPNEA; EDUCATIONAL STATUS; EMERGENCY WARD; ETHNICITY; FATIGUE; FEMALE; FOLLOW UP; GROUPS BY AGE; HAZARD RATIO; HEALTH CARE UTILIZATION; HEART DISEASE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREVALENCE; PROPORTIONAL HAZARDS MODEL; SMOKING; UNITED STATES; VERY ELDERLY; WELLBEING; CHRONIC DISEASE; DAILY LIFE ACTIVITY; GERIATRIC ASSESSMENT; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SYMPTOM ASSESSMENT;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ANXIETY; CHRONIC DISEASE; COMORBIDITY; DEPRESSION; DYSPNEA; FEMALE; GERIATRIC ASSESSMENT; HOSPITALIZATION; HUMANS; MALE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SYMPTOM ASSESSMENT; UNITED STATES;

EID: 84992028915     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.14313     Document Type: Article

References (26)

1. Gysels M, Higginson IJ. Access to services for patients with chronic obstructive pulmonary disease: The invisibility of breathlessness. J Pain Symptom Manage 2008;36:451–460.
2. Abernethy AP, Currow DC, Frith P et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003;327:523–528.
3. Johnson MJ, Currow DC, Booth S. Prevalence and assessment of breathlessness in the clinical setting. Expert Rev Respir Med 2014;8:151–161.
4. Steinhauser KE, Christakis NA, Clipp EC et al. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000;284:2476–2482.
5. Williams S; IMPRESS Breathlessness Working Party. IMPRESS Guide to Breathlessness Methodology Definitions Scope Prevalence, 2013 [on-line]. Available at http://www.impressresp.com/index.php?option=com_docman&Itemid=82 Accessed June 12, 2015.
6. National Hospital Ambulatory Medical Care Survey: 2011 Emergency Department Summary Tables, 2012 [on-line]. Available at http://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2011_ed_web_tables.pdf Accessed June 12, 2015.
7. Currow DC, Clark K, Mitchell GK et al. Prospectively collected characteristics of adult patients, their consultations and outcomes as they report breathlessness when presenting to general practice in Australia. PLoS ONE 2013;8:e74814.
8. Parshall MB, Schwartzstein RM, Adams L et al. An official American Thoracic Society statement: Update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012;185:435–452.
9. Booth S, Bausewein C, Higginson I et al. Pharmacological treatment of refractory breathlessness. Expert Rev Respir Med 2009;3:21–36.
10. Bredin M, Corner J, Krishnasamy M et al. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 1999;318:901–904.
11. Ekstrom MP, Abernethy AP, Currow DC. The management of chronic breathlessness in patients with advanced and terminal illness. BMJ 2015;349:g7617.
12. World Health Organization BMI classification, 2015 [on-line]. Available at http://apps.who.int/bmi/index.jsp?introPage=intro_3.html Accessed August 24, 2015.
13. Wallace RB, Herzog AR, Ofstedal MB. Documentation of Affective Functioning Measures in the Health and Retirement Study. Ann Arbor, MI: University of Michigan, 2000.
14. Beck AT, Epstein N, Brown G et al. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 1988;56:893–897.
15. Marciniuk DD, Goodridge D, Hernandez P et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline. Can Respir J 2011;18:69–78.
16. Stenton C. The MRC breathlessness scale. Occup Med 2008;58:226–227.
17. Ho SF, O'Mahony MS, Steward JA et al. Dyspnoea and quality of life in older people at home. Age Ageing 2001;30:155–159.
18. Currow DC, Plummer JL, Crockett A et al. A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage 2009;38:533–545.
19. Guenette JA, Jensen D, Webb KA et al. Sex differences in exertional dyspnea in patients with mild COPD: Physiological mechanisms. Respir Physiol Neurobiol 2011;177:218–227.
20. Gijsbers van Wijk CM, Huisman H, Kolk AM. Gender differences in physical symptoms and illness behavior. A health diary study. Soc Sci Med 1999;49:1061–1074.
21. Simon ST, Higginson IJ, Benalia H et al. Episodic and continuous breathlessness: A new categorization of breathlessness. J Pain Symptom Manage 2013;45:1019–1029.
22. Yourman LC, Lee SJ, Schonberg MA et al. Prognostic indices for older adults: A systematic review. JAMA 2012;307:182–192.
23. Walter LC, Covinsky KE. Cancer screening in elderly patients: A framework for individualized decision making. JAMA 2001;285:2750–2756.
24. Fallon M. Palliation of breathlessness. Clin Med 2006;6:133–136.
25. Mularski RA, Reinke LF, Carrieri-Kohlman V et al. An official American Thoracic Society workshop report: Assessment and palliative management of dyspnea crisis. Ann Am Thorac Soc 2013;10:S98–S106.
26. Currow DC, Johnson MJ. Distilling the essence of breathlessness: The first vital symptom. Eur Respir J 2015;45:1526–1528.